Cargando…

Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension

OBJECTIVE: To determine the levels of circulating copeptin in patients with pulmonary arterial hypertension (PAH), and to evaluate its relation with disease severity, outcome and response to treatment. BACKGROUND: Vasopressin is a key regulator of body fluid homeostasis. The co-secreted protein cope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nickel, Nils P, Lichtinghagen, Ralf, Golpon, Heiko, Olsson, Karen M, Brand, Korbinian, Welte, Tobias, Hoeper, Marius M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176098/ https://www.ncbi.nlm.nih.gov/pubmed/24251953 http://dx.doi.org/10.1186/1465-9921-14-130

Ejemplares similares

GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells
por: Nickel, Nils, et al.
Publicado: (2011)

Capillary pCO(2) helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction
por: Olsson, Karen M, et al.
Publicado: (2015)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2015)

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Metacognitive Therapy for Adjustment Disorder in a Patient With Newly Diagnosed Pulmonary Arterial Hypertension: A Case Report
por: Winter, Lotta, et al.
Publicado: (2020)

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy
por: Knudsen, Lars, et al.
Publicado: (2011)

Future perspectives in pulmonary arterial hypertension
por: Simonneau, Gérald, et al.
Publicado: (2016)

The changing landscape of pulmonary arterial hypertension and implications for patient care
por: Hoeper, Marius M., et al.
Publicado: (2014)

Advanced pulmonary arterial hypertension: mechanical support and lung transplantation
por: Bartolome, Sonja, et al.
Publicado: (2017)

Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial Hypertension
por: Park, Da-Hee, et al.
Publicado: (2022)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
por: Marra, Alberto M., et al.
Publicado: (2018)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
por: Kamp, Jan C., et al.
Publicado: (2021)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension
por: Hoeper, Marius M.
Publicado: (2015)

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2020)

Pregnancy in pulmonary arterial hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Olsson, Karen M., et al.
Publicado: (2021)

Pathophysiology of copeptin in kidney disease and hypertension
por: Afsar, Baris
Publicado: (2017)

Copeptin in Patients with Pregnancy-Induced Hypertension
por: Marek, Agnieszka, et al.
Publicado: (2021)

The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department
por: Nickel, Christian H, et al.
Publicado: (2012)

Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables
por: Pausch, Christine, et al.
Publicado: (2023)

The revised definition of pulmonary hypertension: exploring the impact on patient management
por: Simonneau, Gérald, et al.
Publicado: (2019)

Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Park, Da Hee, et al.
Publicado: (2021)

Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
por: Caldarone, Flora, et al.
Publicado: (2022)

Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center Study
por: Fuge, Jan, et al.
Publicado: (2022)

Serum copeptin levels in adolescents with primary hypertension
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension
por: Eichstaedt, Christina A., et al.
Publicado: (2022)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

Liver abnormalities in pulmonary arterial hypertension
por: Nickel, Nils P., et al.
Publicado: (2021)

Copeptin and risk stratification in patients with acute dyspnea
por: Potocki , Mihael, et al.
Publicado: (2010)

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
por: Humbert, Marc, et al.
Publicado: (2023)

Renal Function Interferes with Copeptin in Prediction of Major Adverse Cardiac Events in Patients Undergoing Vascular Surgery
por: Schrimpf, Claudia, et al.
Publicado: (2015)

Copeptin levels in patients with coronary artery ectasia
por: Yavcin, Ozkan, et al.
Publicado: (2019)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
por: Kramm, Thorsten, et al.
Publicado: (2018)

Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting
por: Treskova, Marina, et al.
Publicado: (2017)

Potential Roles of Acute Phase Proteins in Cancer: Why Do Cancer Cells Produce or Take Up Exogenous Acute Phase Protein Alpha1-Antitrypsin?
por: Janciauskiene, Sabina, et al.
Publicado: (2021)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
por: Gall, Henning, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ga49lg10vn70ba7s97k18frhmi